Inactivated vaccines based on alternatives to wild-type seed virus.
Chumakov
K
K
Center for Biologics Evaluation and Research, FDA, Rockville, MD 20852, USA.
Dragunsky
E
E
Ivshina
A
A
Enterline
J
J
Wells
V
V
Nomura
T
T
Gromeier
M
M
Wimmer
E
E
D000818:Animals; D000882:Haplorhini; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D011051:Poliomyelitis / Q000276:immunology / Q000517:prevention & control*; D017955:Poliovirus / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity; D011054:Poliovirus Vaccine, Inactivated / Q000276:immunology*; D011055:Poliovirus Vaccine, Oral / Q000276:immunology; D012229:Rhinovirus / Q000235:genetics / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology; D014774:Virulence
D011054:Poliovirus Vaccine, Inactivated; D011055:Poliovirus Vaccine, Oral; D014614:Vaccines, Synthetic